Salivary Biomarkers for Alzheimer’s Disease and Related Disorders
Abstract The search for accessible and cost-effective biomarkers to complement current cerebrospinal fluid (CSF) and imaging biomarkers in the accurate detection of Alzheimer disease (AD) and other common neurodegenerative disorders remains a challenging task. The advances in ultra-sensitive detecti...
Main Authors: | Nicholas J. Ashton, Mark Ide, Henrik Zetterberg, Kaj Blennow |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2019-12-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-019-00168-1 |
Similar Items
-
Editorial: Blood Biomarkers of Neurodegenerative Diseases
by: Thomas K. Karikari, et al.
Published: (2022-06-01) -
Salivary Biomarkers for Alzheimer’s Disease: A Systematic Review with Meta-Analysis
by: Kacper Nijakowski, et al.
Published: (2024-01-01) -
Repeated lumbar punctures within 3 days may affect CSF biomarker levels
by: Martin Olsson, et al.
Published: (2019-12-01) -
Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease
by: Josef Marksteiner, et al.
Published: (2022-09-01) -
A Western‐style dietary pattern is associated with cerebrospinal fluid biomarker levels for preclinical Alzheimer's disease—A population‐based cross‐sectional study among 70‐year‐olds
by: Jessica Samuelsson, et al.
Published: (2021-01-01)